Fundamental Analysis of MAUNA KEA TECHNOLOGIES(EPA:ALMKT) stock

Fundamental Rating

Taking everything into account, ALMKT scores 2 out of 10 in our fundamental rating. ALMKT was compared to 53 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ALMKT have multiple concerns. While showing a medium growth rate, ALMKT is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALMKT has reported negative net income.

In the past year ALMKT has reported a negative cash flow from operations.

ALMKT had negative earnings in each of the past 5 years.

ALMKT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ALMKT's Return On Assets of -16.25% is on the low side compared to the rest of the industry. ALMKT is outperformed by 72.55% of its industry peers.

		Industry Rank	Sector Rank
ROA	-16.25%
ROE	N/A
ROIC	N/A

ROA(3y)-42.36%

ROA(5y)-50.76%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALMKT has a better Operating Margin (11.75%) than 60.78% of its industry peers.

ALMKT has a worse Gross Margin (33.62%) than 82.35% of its industry peers.

		Industry Rank	Sector Rank
OM	11.75%
PM (TTM)	N/A
GM	33.62%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALMKT does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALMKT has been increased compared to 1 year ago.

The number of shares outstanding for ALMKT has been increased compared to 5 years ago.

The debt/assets ratio for ALMKT has been reduced compared to a year ago.

2.2 Solvency

ALMKT has an Altman-Z score of -1.29. This is a bad value and indicates that ALMKT is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of ALMKT (-1.29) is worse than 82.35% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-1.29

ROIC/WACCN/A

WACC6.5%

2.3 Liquidity

A Current Ratio of 0.54 indicates that ALMKT may have some problems paying its short term obligations.

ALMKT has a worse Current ratio (0.54) than 94.12% of its industry peers.

A Quick Ratio of 0.43 indicates that ALMKT may have some problems paying its short term obligations.

ALMKT has a Quick ratio of 0.43. This is amonst the worse of the industry: ALMKT underperforms 88.24% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.54
Quick Ratio	0.43

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 69.76% over the past year.

The Revenue has grown by 40.11% in the past year. This is a very strong growth!

The Revenue has been growing by 9.16% on average over the past years. This is quite good.

EPS 1Y (TTM)69.76%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-9.71%

Revenue 1Y (TTM)40.11%

Revenue growth 3Y17.08%

Revenue growth 5Y9.16%

Sales Q2Q%-10.39%

3.2 Future

ALMKT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.33% yearly.

ALMKT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.60% yearly.

EPS Next Y41.74%

EPS Next 2Y31.38%

EPS Next 3Y24.33%

EPS Next 5YN/A

Revenue Next Year12.04%

Revenue Next 2Y13.02%

Revenue Next 3Y13.6%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALMKT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year ALMKT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

84.31% of the companies in the same industry are more expensive than ALMKT, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	13.26

4.3 Compensation for Growth

ALMKT's earnings are expected to grow with 24.33% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y31.38%

EPS Next 3Y24.33%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALMKT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MAUNA KEA TECHNOLOGIES

EPA:ALMKT (9/13/2024, 7:00:00 PM)

0.352

-0.01 (-1.68%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap22.73M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-16.25%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	11.75%
PM (TTM)	N/A
GM	33.62%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.46

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.54
Quick Ratio	0.43
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)69.76%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y41.74%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)40.11%

Revenue growth 3Y17.08%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

MAUNA KEA TECHNOLOGIES (ALMKT.PA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens